A study that reveals a new way to delay the development of Alzheimer's disease

Researchers, from the Ican College of Medicine in Mount Cenae, USA, have identified a new way to slow down the development of Alzheimer’s disease, or even stop it, in a move that can help develop a new treatment for the disease, leading to a gradual memory loss. The study published in the journal Neuroscience provides an insight into the role of interactive star cells, and the ‘Blicine-B1’ protein in the pathological physiology of Alzheimer’s disease, and the study says that this protein can improve the ability of the brain to remove amyloid plates, which is the characteristic of the Alzheimer’s disease. The researchers also found that interactive star cells, a type of brain cell that is activated in response to infection or disease, plays a crucial role in this process, as it helps to control the spacing around amyloid plates, affecting how other brain cells reach and remove these harmful deposits. What is Alzheimer’s disease? Alzheimer’s disease is a progressive nerve degenerational disorder, characterized by cognitive degradation, memory loss and the pathological features of Alzheimer’s, includes the presence of amyloid beta plates and nerve fibroids consisting of tu -to -to -to -to -to -to -to -to -to -to -to -to -to -to -to -to -to -to -to -to -it -to -tu. Although much research has focused on neurons in the context of Alzheimer’s disease, the increasing evidence indicates that glial cells, especially star cells, play a decisive role in the development of the disease. One of the proteins that has received attention in recent studies is the B1 B1 protein, which is a future known for its role in nervous development and the direction of nerve axles. Star cells are the most abundant glial cells in the central nervous system, and they perform various functions, including maintaining the integrity of the brain blood barrier, the regulation of blood flow and the adjustment of cerebral activity. Interactive stellar disease and the star -cells are subject to a transformation known as interactive star -cell disease, and this process contains formal changes, the spread of these cells and the secretion of a group of proteins that increase the risk of the disease. Interactive stars can have preventative effects, but at the same time these cells can tolerate nerves; These cells can secrete neurological nutritional factors and antioxidants that support the survival of neurons, and they can also release infections that stimulate cytokines, which contribute to nerve inflammation and nerve cell damage. The researchers say that the double nature of interactive star cells makes it an important element in Alzheimer’s disease, and that the B1 B1 protein interacts with these cells, which affect the dynamics of the cellular structure and cellular formation of the central nervous system. The new study showed that the “Blicine-B1” signals can affect the whirl and neurons, and that protein can also be used to adjust the inflammatory response by communicating with different signals. The treatment of Alzheimer’s disease, the lead author of the study, Roland Friedel, an associate professor of neuroscience and neurosurgery on Mount Cenae, says the results provide a promising way to develop new treatments, by improving how cells interact with these harmful plates, as the study new paths for the developments. cellular reactions in the development of cellular reactions in cellular reactions in the development of cellular reactions in cellular reactions. degenerative diseases. The researchers say that the role of ‘blicine-b1’ understands in the interactive star cells, and its contribution to Alzheimer’s diseases opens new horizons to treatment interventions, as the target of the protein signals in the star cells can adjust their interactive condition, which can reduce the nerve stem and protect neurons from damage. The research team confirms that although their findings are “great progress” in combating Alzheimer’s disease, more research is needed to translate these discoveries into treatments for people.